Abstract:Protein tyrosine phosphatases (PTPs) are critical regulators of cellular signal transduction that catalyze the hydrolytic dephosphorylation of phosphotyrosine in substrate proteins. Among several conserved features in classical PTP domains are an active-site cysteine residue that is necessary for catalysis and a "backdoor" cysteine residue that can serve to protect the active-site cysteine from irreversible oxidation. Curiously, two biologically important phosphatases, Src homology domain-containing PTPs 2 and 1 (SHP2 and SHP1), each contain an additional backdoor cysteine residue at a position of the PTP domain that is occupied by proline in almost all other classical PTPs (position 333 in human SHP2 numbering). Here we show that the presence of cysteine 333 significantly destabilizes the fold of the PTP domains in the SHPs. We find that replacement of cysteine 333 with proline confers increased thermal stability on the SHP2 and SHP1 PTP domains, as measured by temperature-dependent activity assays and differential scanning fluorimetry. Conversely, we show that substantial destabilization of the PTP-domain fold is conferred by introduction of a non-natural cysteine residue in a non-SHP PTP that contains proline at the 333 position. It has previously been suggested that the extra backdoor cysteine of the SHP PTPs may work in tandem with the conserved backdoor cysteine to provide protection from irreversible oxidative enzyme inactivation. If so, our current results suggest that, during the course of mammalian evolution, the SHP proteins have developed extra protection from oxidation at the cost of the thermal instability that is conferred by the presence of their PTP domains' second backdoor cysteine.

Single Ion Pair Is Essential for Stabilizing SHP2's Open Conformation

Study of SHP-2 (PTPN11) Allosterism on Structural Movement Using Solution Perturbed Molecular Dynamics Simulation

Discriminating between competing models for the allosteric regulation of oncogenic phosphatase SHP2 by characterizing its active state

Phosphopeptide binding to the N-SH2 domain of tyrosine phosphatase SHP2 correlates with the unzipping of its central β-sheet

Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformation.

Phosphotyrosine couples peptide binding and SHP2 activation via a dynamic allosteric network

Exploring the Allosteric Mechanism of Src Homology-2 Domain-Containing Protein Tyrosine Phosphatase 2 (SHP2) by Molecular Dynamics Simulations.

A novel partially open state of SHP2 points to a “multiple gear” regulation mechanism

Destabilization of the SHP2 and SHP1 protein tyrosine phosphatase domains by a non-conserved "backdoor" cysteine

Crystal Structure of Human Protein-Tyrosine Phosphatase SHP-1.

The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain

Molecular recognition of ITIM/ITSM domains with SHP2 and their allosteric effect

Antagonism Between Binding Site Affinity and Conformational Dynamics Tunes Alternative Cis-Interactions Within Shp2.

Catalytically inactive SHP1-C453S mutant gain of “robust LLPS” function

Deep mutational scanning of a multi-domain signaling protein reveals mechanisms of regulation and pathogenicity

SHP-1 Variants Broaden the Understanding of pH-Dependent Activities in Protein Tyrosine Phosphatases

Mechanism of SHP2 activation by bis-Tyr-phosphorylated Gab1

Mechanisms controlling membrane recruitment and activation of autoinhibited SHIP1

Quantitation of autoinhibitory defects in pathogenic SHP2 mutants by differential scanning fluorimetry

SH2 Domains Serve as Lipid-Binding Modules for pTyr-Signaling Proteins.

Therapeutic Potential of Targeting SHP2 in Human Developmental Disorders and Cancers